Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitric oxide plus iloprost for organ protection during cardiopulmonary bypass in children with septal defects
ChiCTR-TRC-08000242Phase 4Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Dec 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of nitric oxide and iloprost in atrial septal defect (ASD) and Ventricular Septal Defect (VSD) (4 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: elastase, platelet-activating factor and 4 more. Started Dec 2008; status: completed.
02
Drugs
nitric oxideiloprost
03
Conditions
atrial septal defect (ASD)Ventricular Septal Defect (VSD)
Beyond the preview
Go deeper on ChiCTR-TRC-08000242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-08000242.